Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 5 studies | 22% ± 4% | |
retina horizontal cell | 4 studies | 21% ± 2% | |
glutamatergic neuron | 4 studies | 25% ± 5% | |
astrocyte | 4 studies | 21% ± 4% | |
interneuron | 4 studies | 21% ± 4% | |
neuron | 3 studies | 22% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 20% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 93% | 643.85 | 2462 / 2642 | 98% | 12.65 | 694 / 705 |
skin | 95% | 928.29 | 1713 / 1809 | 97% | 22.50 | 457 / 472 |
pancreas | 100% | 1248.00 | 328 / 328 | 90% | 5.49 | 160 / 178 |
ovary | 100% | 2018.74 | 180 / 180 | 89% | 6.62 | 382 / 430 |
uterus | 100% | 9534.83 | 170 / 170 | 88% | 10.19 | 406 / 459 |
prostate | 100% | 2486.80 | 245 / 245 | 87% | 5.80 | 435 / 502 |
breast | 99% | 892.07 | 456 / 459 | 83% | 5.95 | 926 / 1118 |
esophagus | 100% | 2346.00 | 1438 / 1445 | 81% | 8.46 | 148 / 183 |
lung | 99% | 1247.61 | 575 / 578 | 81% | 6.70 | 933 / 1155 |
thymus | 96% | 546.36 | 629 / 653 | 75% | 3.66 | 455 / 605 |
bladder | 100% | 1374.00 | 21 / 21 | 67% | 4.52 | 340 / 504 |
intestine | 98% | 1868.87 | 948 / 966 | 56% | 2.78 | 297 / 527 |
stomach | 84% | 812.13 | 303 / 359 | 63% | 3.71 | 180 / 286 |
kidney | 69% | 319.82 | 61 / 89 | 50% | 2.40 | 447 / 901 |
blood vessel | 100% | 1844.18 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 37.43 | 80 / 80 |
adipose | 100% | 1076.25 | 1198 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 8.38 | 42 / 45 |
spleen | 92% | 504.42 | 221 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 72% | 277.14 | 185 / 258 | 18% | 0.67 | 42 / 230 |
heart | 87% | 526.77 | 749 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.39 | 4 / 29 |
muscle | 12% | 37.64 | 94 / 803 | 0% | 0 | 0 / 0 |
liver | 1% | 5.66 | 2 / 226 | 10% | 0.54 | 42 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1901621 | Biological process | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0060170 | Cellular component | ciliary membrane |
GO_0097386 | Cellular component | glial cell projection |
GO_0005929 | Cellular component | cilium |
GO_0005886 | Cellular component | plasma membrane |
GO_0043005 | Cellular component | neuron projection |
GO_0055037 | Cellular component | recycling endosome |
GO_0030666 | Cellular component | endocytic vesicle membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GPR161 |
Protein name | G-protein coupled receptor 161 (G-protein coupled receptor RE2) G protein-coupled receptor 161 |
Synonyms | hCG_42392 |
Description | FUNCTION: Key negative regulator of Shh signaling, which promotes the processing of GLI3 into GLI3R during neural tube development. Recruited by TULP3 and the IFT-A complex to primary cilia and acts as a regulator of the PKA-dependent basal repression machinery in Shh signaling by increasing cAMP levels, leading to promote the PKA-dependent processing of GLI3 into GLI3R and repress the Shh signaling. In presence of SHH, it is removed from primary cilia and is internalized into recycling endosomes, preventing its activity and allowing activation of the Shh signaling. Its ligand is unknown (By similarity). . |
Accessions | ENST00000546300.5 [Q8N6U8-5] ENST00000271357.9 ENST00000367838.5 [Q8N6U8-1] A0A0A0MQW8 ENST00000367835.1 [Q8N6U8-1] ENST00000539777.5 [Q8N6U8-4] ENST00000367836.5 [Q8N6U8-3] ENST00000537209.5 [Q8N6U8-6] ENST00000682931.1 [Q8N6U8-1] Q8N6U8 |